Pre-salvage RT PSA predictive of hormone therapy benefit with salvage RT for recurrent prostate cancer
Initial results of NRG Oncology Clinical Trial RTOG 9601 in men with biochemically recurrent prostate cancer receiving salvage radiotherapy (SRT) demonstrated improvement in OS from the addition of long-term hormone therapy ...
Sep 16, 2019
0
3